Kakyung Kim

Archives
Log in
Subscribe
September 28, 2026

๐Ÿ“ˆ econ-radar 2026-09-28 ยท Mirum brelovitug: HDV ์ตœ์ดˆ ์น˜๋ฃŒ์ œ์˜ ๋ถ„๊ธฐ์ 

๐Ÿ“ˆ econ-radar 2026-09-28 ยท Mirum brelovitug: HDV ์ตœ์ดˆ ์น˜๋ฃŒ์ œ์˜ ๋ถ„๊ธฐ์ 

๐Ÿ“ˆ econ-radar ๋ฐ์ผ๋ฆฌ

2026-09-28

์ œ์•ฝยท๋ฐ”์ด์˜คยทAI์— ๋ฌด๊ฒŒ๋ฅผ ๋‘” ๊ฒฝ์ œ ๋ฐ์ผ๋ฆฌ โ€” ์‚ฐ์—…๊ตฌ์กฐยทํˆฌ์žยท์‹œ์žฅ 3๋ Œ์ฆˆ

At a Glance

๐Ÿ’ฐ ์ถ”์„ ๋ณต๊ท€ ์ฒซ๋‚  KOSPI๊ฐ€ 6,889pt(-2.70%)๋กœ ๊ธ‰๋ฝํ–ˆ๋‹ค. ์™ธ๊ตญ์ธ 3.1์กฐ์› ์ˆœ๋งค๋„์— ์‚ผ์„ฑ์ „์ž(-5.25%)ยทSKํ•˜์ด๋‹‰์Šค(-4.83%)๊ฐ€ ์ง€์ˆ˜๋ฅผ ๋Œ์–ด๋‚ด๋ ธ๋‹ค.

๐Ÿ›ข๏ธ ๋ฏธ-์ด๋ž€ ํ˜‘์ƒ ๊ต์ฐฉ์œผ๋กœ Brent ์›์œ ๊ฐ€ $107.34๊นŒ์ง€ ์น˜์†Ÿ์•˜๋‹ค. ๋‚ด์ผ(9/29)์—๋Š” Section 232 ์˜์•ฝํ’ˆ ๊ด€์„ธ Annex III ์ „๋ฉด ๋ฐœํšจ๊ฐ€ ์˜ˆ์ •๋ผ ์—๋„ˆ์ง€ยท์ œ์•ฝ ์ด์ค‘ ์ถฉ๊ฒฉ์ด ํ˜„์‹คํ™”๋๋‹ค.

๐Ÿงฌ Mirum Pharmaceuticals์˜ ๋งŒ์„ฑ HDV ์น˜๋ฃŒ์ œ brelovitug AZURE-1 Phase 3 ํƒ‘๋ผ์ธ ๊ฒฐ๊ณผ๊ฐ€ ์˜ค๋Š˜ 21:30 KST์— ๋ฐœํ‘œ๋œ๋‹ค. Phase 2b์—์„œ 1์ฐจ ๋‹ฌ์„ฑ ์„ ๋ก€๊ฐ€ ์žˆ์–ด ์—…๊ณ„์˜ ๊ธฐ๋Œ€๊ฐ€ ํฌ๋‹ค.

๐Ÿš€ ADARx Pharmaceuticals๊ฐ€ $446.3M(์•ฝ 6,050์–ต์›) RNAi ๋Œ€ํ˜• IPO๋ฅผ ์„ฑ๊ณต์‹œ์ผฐ๊ณ , Anthropic์€ Infosys์™€ ๊ทœ์ œ ์‚ฐ์—… ํŠนํ™” AI ์—์ด์ „ํŠธ ํŒŒํŠธ๋„ˆ์‹ญ์„ ๊ณต๋™ ๋ฐœํ‘œํ–ˆ๋‹ค.

Today's Top 5

Market

1. KOSPI ์ถ”์„ ๋ณต๊ท€ ์ฒซ๋‚  6,889pt(-2.70%) โ€” ์™ธ๊ตญ์ธ 3.1์กฐ์› ์ˆœ๋งค๋„

์ถ”์„ ์—ฐํœด(9/24~9/27)๋ฅผ ๋งˆ์น˜๊ณ  ์žฌ๊ฐœ์žฅํ•œ KOSPI๊ฐ€ ์žฅ์ค‘ 6,998๊นŒ์ง€ ํ•˜๋ฝํ•˜๋ฉฐ 6,889.74pt(-2.70%)๋กœ ๋งˆ๊ฐํ–ˆ๋‹ค. ์‚ผ์„ฑ์ „์ž 270,500์›(-5.25%), SKํ•˜์ด๋‹‰์Šค 1,772,000์›(-4.83%) ๊ธ‰๋ฝ์ด ์ง€์ˆ˜๋ฅผ ๋Œ์–ด๋‚ด๋ ธ๊ณ , ์™ธ๊ตญ์ธ์€ ํ•ฉ์‚ฐ ์•ฝ 3.1์กฐ์›(์•ฝ 23์–ต๋‹ฌ๋Ÿฌ) ์ˆœ๋งค๋„๋ฅผ ์Ÿ์•„๋ƒˆ๋‹ค.

โ†— Business Today

Market

2. ๋ฏธ-์ด๋ž€ ํ˜‘์ƒ ๊ต์ฐฉ ์‹ฌํ™” โ€” Brent $107.34, Section 232 D-1

Trump์ด ์ด๋ž€์˜ 7์ผ ๋‹จ๊ณ„์  ํ˜ธ๋ฅด๋ฌด์ฆˆ ์žฌ๊ฐœ๋ฐฉ ์ œ์•ˆ์„ ๊ณต๊ฐœ ๊ฑฐ๋ถ€ํ•˜๋ฉด์„œ ์œ ๊ฐ€๊ฐ€ ๊ธ‰๋“ฑํ–ˆ๋‹ค. Brent $107.34(+2.89%), WTI $94.14(+1.87%). ์ด๋ž€์€ ํ•ด๊ตฐ ๋ด‰์‡„ ํ•ด์ œยท์ œ์žฌ ์™„ํ™”ยท์œ ์ „ํ˜‘์ •์„ ์„ ํ–‰์กฐ๊ฑด์œผ๋กœ ๊ณ ์ˆ˜ ์ค‘์ด๋‹ค. ๋‚ด์ผ(9/29) Section 232 ์˜์•ฝํ’ˆ ๊ด€์„ธ Annex III ์ „๋ฉด ๋ฐœํšจ์™€ ๊ฒน์ณ ์—๋„ˆ์ง€ยท์ œ์•ฝ ์ด์ค‘ ์ถฉ๊ฒฉ ์šฐ๋ ค๊ฐ€ ์ปค์กŒ๋‹ค.

โ†— CNBC

Bio

3. Mirum brelovitug AZURE-1 Phase 3 ํƒ‘๋ผ์ธ โ€” ์˜ค๋Š˜ 21:30 KST ๋ฐœํ‘œ

Mirum Pharmaceuticals๊ฐ€ ๋งŒ์„ฑ HDV(๋ธํƒ€ ๋ฐ”์ด๋Ÿฌ์Šค ๊ฐ„์—ผ) ์น˜๋ฃŒ์ œ brelovitug์˜ Phase 3 ์ž„์ƒ AZURE-1 ํƒ‘๋ผ์ธ ๊ฒฐ๊ณผ๋ฅผ ์˜ค๋Š˜ 8:30am ET(KST 21:30) ํˆฌ์ž์ž ์ฝœ๋กœ ๋ฐœํ‘œํ•œ๋‹ค. 1์ฐจ ํ‰๊ฐ€๋ณ€์ˆ˜๋Š” ๋ฐ”์ด๋Ÿฌ์Šค ๋ฐ˜์‘ + ALT ์ •์ƒํ™” ๋ณตํ•ฉ ์ง€ํ‘œ. ๋“ฑ๋ก ํ™˜์ž ์•ฝ 200๋ช…, Phase 2b์—์„œ 1์ฐจ ๋‹ฌ์„ฑ ์„ ๋ก€๊ฐ€ ์žˆ๋‹ค.

โ†— BioSpace

Bio

4. ADARx Pharmaceuticals $446.3M RNAi IPO โ€” 10๋…„ ๋งŒ์˜ ๋Œ€ํ˜• RNA ์ƒ์žฅ

9์›” 24์ผ(์ˆ˜) ADARx Pharmaceuticals(NASDAQ: ADRX)๊ฐ€ $17(ํฌ๋ง ์ƒ๋‹จ)์— 2,628๋งŒ ์ฃผ ๊ณต๋ชจํ•ด $446.3M(์•ฝ 6,050์–ต์›)์„ ์กฐ๋‹ฌํ–ˆ๋‹ค. AbbVie์˜ ์ „๋žต์  ๊ณต๋™ ํˆฌ์ž($89M)๋ฅผ ํฌํ•จํ•œ๋‹ค. ํŒŒ์ดํ”„๋ผ์ธ: ๋ณด์ฒด ๋งค๊ฐœ ์งˆํ™˜ยท์œ ์ „์„ฑ ํ˜ˆ๊ด€๋ถ€์ข…ยทํ˜ˆ์ „์„ฑ ์งˆํ™˜ 3๊ฐœ ์ž„์ƒ ๋‹จ๊ณ„ siRNA.

โ†— BioPharma Dive

AI

5. Anthropic ร— Infosys ์—”ํ„ฐํ”„๋ผ์ด์ฆˆ AI ์—์ด์ „ํŠธ ํŒŒํŠธ๋„ˆ์‹ญ

Anthropic๊ณผ Infosys๊ฐ€ ๊ทœ์ œ ์‚ฐ์—…(ํ†ต์‹ ยท๊ธˆ์œต์„œ๋น„์Šคยท์ œ์กฐยท์†Œํ”„ํŠธ์›จ์–ด ๊ฐœ๋ฐœ) ์ „๋ฌธ AI ์—์ด์ „ํŠธ ๊ฐœ๋ฐœ ํ˜‘๋ ฅ์„ ๊ณต๋™ ๋ฐœํ‘œํ–ˆ๋‹ค. Claude Agent SDK + Infosys Topaz๋ฅผ ๊ฒฐํ•ฉํ•ด ์žฅ๊ธฐยท๋ณต์žก ์—…๋ฌด ํ”„๋กœ์„ธ์Šค์—์„œ ์ง€์† ์ž‘๋™ํ•˜๋Š” ์—์ด์ „ํŠธ๋ฅผ ๊ตฌ์ถ•ํ•˜๋Š” ๊ฒƒ์ด ๋ชฉํ‘œ๋‹ค.

โ†— Infosys ๋ณด๋„์ž๋ฃŒ

๐Ÿ—ฃ ์˜ค๋Š˜์˜ ํ™”์ œ

HDV Phase 3 ํƒ‘๋ผ์ธ์€ ์˜ค๋Š˜ 21:30 KST โ€” ์„ฑ๊ณต ์‹œ ์ตœ์ดˆ FDA ์‹ ์ฒญ์˜ ๋ฐœํŒ, ์‹คํŒจ ์‹œ ์ฃผ๊ฐ€ ์ด์ง„(binary) ์ถฉ๊ฒฉ์ด ๋œ๋‹ค.

์ „์ฒด ๋ฆฌํฌํŠธ ๋ณด๊ธฐ โ†’

Deep Dive ยท Demand ยท Investment ยท Companies ยท Sources ์ „์ฒด๋Š” ์œ„ ๋งํฌ์—์„œ ๋ณด์‹ค ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ…”๋ ˆ๊ทธ๋žจ @econradar ๋กœ๋„ ๋ฐ›๊ธฐ

econ-radar ยท 2026-09-28

ํˆฌ์ž ์ฐธ๊ณ ์šฉ ์ •๋ณด์ž…๋‹ˆ๋‹ค. ์ตœ์ข… ํŒ๋‹จ๊ณผ ์ฑ…์ž„์€ ๋ณธ์ธ์—๊ฒŒ ์žˆ์Šต๋‹ˆ๋‹ค.

Don't miss what's next. Subscribe to Kakyung Kim:
โ† Newer ๐Ÿ“ˆ econ-radar 2026-09-29 ยท Section 232 ์˜์•ฝํ’ˆ ๊ด€์„ธ ์ „๋ฉด ๋ฐœํšจ(Section 232 Pharma Tariff) Older โ†’ [์ฃผ๊ฐ„] econ-radar 2026๋…„ 39์ฃผ ๋™ํ–ฅ ()
Powered by Buttondown, the easiest way to start and grow your newsletter.